Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don Miller who wrote (3040)	5/26/1999 7:22:00 PM
From: scaram(o)uche	Read Replies (1) of 10280

>> Again Richard please pardon my memory, but I believe you are new to this board, so I would like to know a little more. << OK. You joined SI in March of this year, and my first post to this thread was 9/9/97....... exchange2000.com >> Where does the second doc. office visit occur? << Patients were treated with either 300mg anti-IgE or placebo via subcutaneous (under the skin) injection -- two injections given three or four weeks apart (from the GNE release) >> Since you were exposed to the knowledge of this drug have you increased your position in either GNE or Novartis, or managed to buy into Tanox somehow? << I haven't owned GNE for at least 10 years, but I'm a 49% owner of Novartis.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next